The Evaluation of Benzodiazepine-induced Dysphagia Using High-resolution Manometry

Intern Med. 2023 Dec 1;62(23):3537-3540. doi: 10.2169/internalmedicine.1539-22. Epub 2023 Apr 14.

Abstract

We evaluated the pathophysiology of dysphagia considered to be induced by benzodiazepine using high-resolution manometry (HRM). A 53-year-old man with Parkinson disease had had dysphagia for over 3 months. He had been taking several benzodiazepines for more than four years. Two weeks after discontinuation of the benzodiazepines, HRM revealed increased pharyngeal contractility and residual pressure at the upper esophageal sphincter. A video-fluoroscopic swallowing study showed improved pharyngeal bolus passage. Benzodiazepine-induced dysphagia may be due to the muscle relaxant effects on the swallowing muscles and attenuation of the barrier function which prevents reflux from the esophagus into the pharynx.

Keywords: Parkinson disease; drug-induced dysphagia; muscle relaxant effect; pharyngeal contraction; upper esophageal sphincter.

Publication types

  • Case Reports

MeSH terms

  • Benzodiazepines
  • Deglutition / physiology
  • Deglutition Disorders* / chemically induced
  • Esophageal Sphincter, Upper
  • Humans
  • Male
  • Manometry
  • Middle Aged
  • Pharynx / physiology

Substances

  • Benzodiazepines